期刊文献+

我国药品“含贿”问题的成因及治理

Causes and Treatment of “Bribery” in Domestic Drugs
下载PDF
导出
摘要 药品"含贿"是造成近年来我国药品价格虚高的重要原因,既增加了患者的负担,也造成了医患关系的紧张。其成因主要是医患间委托—代理关系下,医生得不到有效激励,劳动力消耗得不到完全补偿;患者无法有效监督医生,使医生产生了自身利益最大化而损害患者利益的行为。药品"含贿"造成了患者福利水平的降低和医生违法违规风险的加大,从如何有效监督医生和加强对医生的激励两个方面提出了相应的治理措施,以期提高医患双方的福利水平。 “Bribery” in drugs is one important reason which has caused the extremely high price of some drugs in our country in recent years . It not only increases patients’ burden , but also results in the tension between doctors and patients .The major cause is that doctors cannot get effective incentives under the entrustment-agent relationship between themselves and their patients .Their labor consumption cannot be fully compensated .Besides ,patients cannot effectively monitor doctors .It thus provides a loophole for the doctors’ damaging patients’ interests for the sake of maximizing their own interests .“Bribery” in drugs leads to patients’ decreasing welfare level and doctors’ risks of violating laws and rules . The paper starts from how to effectively monitor doctors and enhance the incentives ,based on which the author puts forward corresponding treatment measures in order to improve the welfare level for both doctors and patients .
作者 曹璞 辛志虹
出处 《医学与哲学(A)》 北大核心 2014年第4期94-96,共3页 Medicine & Philosophy:Humanistic & Social Medicine Edition
基金 西安医学院2012年科研计划项目"医药企业内外部整合与创新绩效关系的实证研究" 项目编号:12RKX04
关键词 药品 “含贿” 委托 - 代理关系 福利水平 “bribery” in drugs entrustment-agent relationship level of benefits
  • 相关文献

参考文献3

二级参考文献44

  • 1孙福川.医学职业潜规则的颠覆与“伦理生态”的营造——论医学职业精神重构的第一要务[J].医学与哲学(A),2007,28(3):14-17. 被引量:9
  • 2Campbeel E G, Gruen R L, Mountford J, et al. A national survey of physician- industry relationships[J]. NEJM,2007, (356) : 1742 - 50.
  • 3Wazana A. Physicians and the pharmaceutical industry: is a gif ever just a gift? [J]. JAMA, 2000, (283) : 373 - 80.
  • 4Relman A. Separating continuing medical education from pharmaceutical marketing[J]. JAMA,2001, (285) :2 009 - 2 014.
  • 5Blumenthal D. Docters and drug companies[ J ]. NEJM, 2004, (351) : 1 885- 1 890.
  • 6Rawlins M D. Doctors and the drug makers[J]. Lancet, 1984, (2) :276 - 278.
  • 7Kein S M, Mays M Z, Grant D. Interactions between emergency medicine programs and the pharmaceutical industry [ J ]. Acad Emerg Med,2004, (11):19 - 26.
  • 8Komesaroff P A,Kerridge I H. Ethical issues concerning the relationshis between medical practitioners and the pharmaceuteical industry [J]. Med J Aust,2002, (176) : 118 - 121.
  • 9Campbeel E G, Gruen R L, Mountford J, et al. A national survey of physician - industry relationships [ J ] NEJM, 2007, ( 356 ) : 1 742 - 1 750.
  • 10Sieries F S,Brodkey A C,Clearly L M,et al. Medical students'exposure to and attitudes about drug company interactions:a national survey [J].JAMA,2005,(294):1 034- 1 042.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部